Weekly high dose 22 hours infusional 5-fluorouracil plus leucovorin and biweekly cisplatin treatment of advanced/ metastatic gastric cancer
K Tamas, É Végh, Z Szûcs, Á Petrányi, G Bodoky · Zeitschrift für Gastroenterologie · 2004 · Heft 05
Bibliografische Angaben
Zusammenfassung
Introduction: Prognosis of advanced/metastatic gastric cancer is very poor, best supportive care related overall survival is 3–4 month. The purpose of the study was to asses the activity and toxicity of weekly high dose infusional 5- Fluorouracil associated with weekly Leucovrin and biweekly Cisplatin as first- line chemotherapy in patients with advanced or metastatic gastric cancer. Material and methods: An open, non-randomized trial was performed involving 37 patients each of which had histlogically confirmed measurable, locally advanced or metastatic gastric cancer. Adequate WHO performance status, hematholog…